Evaluation of breast symptoms with mammography and ultrasonography by Devolli Disha, Emine et al.
180 Journal of HealtH ScienceS 2011; 1 (3)
Journal of Health Sciences          www.jhsci.ba  Volume 1, Number 3, December 2011
Abstract
Introduction: Aim of the study was to discern which are more frequent symptoms presented in malign and 
benign masses diagnosed by mammography and ultrasonography.
Methods: Our study group consisted of 546 female patients, with breast symptoms such as palpable lumps 
(40.8%), pain in the breast (26%), localized lumpiness or nodularity (13.7%), nipple retraction (11.2%), nipple 
bloody discharge (5.1%) and redness and swelling of the breast (3.1%). All 546 patients were examined by 
ultrasonography and mammography. Biopsy was performed according to the findings of mammography and 
ultrasonography. 
Results: In breast cancer detection ultrasonography showed an efficiency of 79.4% compared to 55.0% for 
mammography in detecting breast lump, in the case of nipple retraction mammography showed an efficiency 
of 89.1% compared to 80.4% for ultrasound, while the lowest efficiency for mammography was in the cases 
with localized lumpiness or nodularity 17.1% compared to 45.7% for ultrasound. In detecting fibrocystic 
changes where the most common symptoms was pain, ultrasonography showed an efficiency of 99.3 % 
compared to 84.2 % for mammography.
Conclusions: Our study confirmed that breast lumps are detectable in the majority of patients with breast 
cancer. The most frequent symptoms in patient with benign lesions were pain or localized discomfort. The 
diagnostic accuracy for carcinomas of the breast and for benign lesions according to symptoms was higher 
for ultrasound than for mammography. © 2011 All rights reserved
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Introduction
Breast cancer represents a significant public health 
problem in Kosovo. Despite the gloomy prognosis, 
increased morbidity and reduced survival time, it 
can be controlled if detection and diagnosis are 
made in the earliest stages in the pre-invasive and 
clinically nonpalpable stages. Bilateral mammog-
raphy should be the first imaging study performed 
in patients over the age of 30 who present with 
breast masses that are suspicious for carcinoma (1). 
The primary reason for performing mammogra-
phy in a patient with a suspicious palpable mass is 
to assess the affected breast for multifocal disease 
and the contralateral breast for suspicious abnor-
malities that should be biopsied concurrently (2).
If mammography is negative in a patient with a 
clinically evident mass and dense breast, ultra-
sound is often suggested as a subsequent imag-
ing study (3, 4). Women under the age of 30 who 
have a focal suspicious palpable abnormality are 
frequently first evaluated with ultrasound (5, 6). 
Many early breast carcinomas may be asymp-
tomatic (7). If the patient has not noticed a lump, 
then symptoms indicating the possible presence of 
breast cancer may include the following: change in 
breast size or shape, skin dimpling, recent nipple 
inversion or skin change, single-duct discharge, 
particularly if bloodstained, axillary lump. Pain or 
discomfort is not usually a symptom of breast can-
cer. A lump is the first symptom in over 80 percent 
of all patients with breast cancer. The nature of pal-
pable lumps is often difficult to determine clinical-
ly, but the following features should raise concern: 
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Hardness, irregularity, focal nodularity, asymme-
try with the other breast, fixation to skin or muscle. 
Mammographic features suggestive of malignancy 
include asymmetry, microcalcifications, a mass or 
architectural distortion. If any of these features are 
identified, a diagnostic mammogram along with 
a breast ultrasound should be performed prior 
to obtaining a biopsy (8-10). Ultrasonographic 
evaluation in addition to mammography can help 
distinguish between solid and cystic lesions, ac-
curately determine the size of a spiculated lesion 
and guide accurate biopsy of a suspicious area 
(11-13). As a screening device, the ultrasound is 
limited by a number of factors, but most notably 
by the failure to detect microcalcification. Ultra-
sonographic features of malignancy include the 
following: Poorly defined borders, heterogeneous 
internal echoes, disruption of the tissue layers, ir-
regular shadowing, superficial echo enhancement, 
depth greater than height, high vascular density 
and flow rates on doppler images (14-17). Nipple 
retraction may be caused by aging, ductectasia or 
breast cancer. A mammogram and breast ultra-
sound will help determine the cause of the nipple 
change (18). Breast discharge is a common prob-
lem and is rarely a symptom of cancer. The char-
acteristics of nipple discharge that should raise 
the index of suspicion for malignancy are spon-
taneous and unilateral discharge that is bloody, 
seroanguineous or watery in consistency and is 
associated with an underlying mass (19). Breast 
pain can be due to many possible causes. Most 
likely breast pain is from hormonal fluctuations 
from menstruation, pregnancy, puberty, meno-
pause, and breastfeeding. Breast pain can also be 
associated with fibrocystic breast disease, but it is 
a very unusual symptom of breast cancer (15, 20).
Aim of the study was to discern which are more 
frequent symptoms presented in malign and be-
nign masses diagnosed by mammography and ul-
trasonography. 
Methods
A group of 546 female patients with breast 
symptoms, such as palpable lumps, pain in 
the breast, nipple discharge, localized lumpi-
ness or nodularity, nipple retraction, and red-
ness and swelling of the breast were examined 
independently with ultrasound and mammog-
raphy, diagnosis was confirmed with biopsy. 
Mammography was performed in a stand type 
Alpha RT imaging, General Electric Medical Sys-
tems. Mediolateral oblique and craniocaudal im-
ages was obtained and assessed carefully. Mam-
mograms were interpreted according to the Breast 
Imaging Reporting and Data System, diagnostic 
categories on a five-point scale. Ultrasound exam-
ination were performed using a high-resolution 
unit (Aloka SSD 620; Tokyo, Japan and Mindray 
DP 1100 Plus) with linear array probe centred at 
7.5 MHz. All ultrasound examination were per-
formed with the patient in a supine position for 
the medial parts of the breast and in a contralateral 
posterior oblique position with arms raised for the 
lateral parts of the breast. Diagnoses were scored 
on a five-point scale identical to the mammo-
graphic BI-RADS categories. A total of 546 breast 
lesions were examined by histological methodol-
ogy. Histopathology results revealed the presence 
of 259 invasive cancers and 287 benign lesions.
Statistical analysis 
χ2 test and student  t-test were used for statistical data 
processing. The significance of differences observed 
was assessed using Pearson’s chi-square test, with 
p< 0.01 considering being statistically significant.
Results 
The study included 546 patients with breast symp-
toms. The most frequent malignant symptoms in 
the 259 cases with breast cancer was lump with 
160 cases or 61.8% , being dominant symptoms, 
breast symptoms
breast changes
benign Malign total
n % n % n %
287 100.0 259 100.0 546 100.0
lump 63 22.0 160 61.8 223 40.8
nipple retraction 15 5.2 46 17.8 61 11.2
Pain 139 48.4 3 1.2 142 26.0
nipple bloody 
discharge 21 7.3 7 2.7 28 5.1
localised 
nodularity 40 13.9 35 13.5 75 13.7
redness and 
swelling (mastitis) 9 3.1 8 3.1 17 3.1
P<0.01
Table 1.  breast symptoms in malign and benign changes
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and significantly more frequent than the benign 
changes, 63 cases or 22.0% of them. In second 
place comes nipple retraction with 46 cases or 
17.8%, significantly more frequent than in be-
nign changes of 5.2%. The 
most frequent symptoms 
in patient with benign le-
sions were pain or local-
ized discomfort with 139 
cases or 48.4%, significantly 
more frequent than in the 
patient with malignant 
lesions, only 1.2%. The 
bloody discharge was most 
frequent in benign lesions, 
but with less frequency, 
7.3%, to 2.7% of malignant 
lesions. Changes between 
malignant and benign le-
sions according to symp-
toms was statistically sig-
nificant (P <0. 01) (Table 1). 
Table 2 shows that among 
the malignant and benign 
changes are presented con-
siderable differences in the 
prevalence rate of symp-
toms and the tendency of 
movement according to 
age group. In malign le-
sions lump had the highest 
rate of prevalence in all age 
groups, especially on young 
patients, 92. 3%, while in 
other groups was 52. 6% 
in age 40-49 up to 63. 9% 
in the age group 60-69. 
Among other symptoms, 
nipple retraction was pre-
sented at over 40 ages and 
tends to increase according 
to age groups, up to 36. 7% 
in age group 70-79%. Table 
3 shows in patient with 
benign lesions, the most 
common symptoms, pain, 
has shown a tendency to 
increase according to age, 
from 11. 4% in the age 
group 30-39 up to a maximum of 65. 1% of age 60-
69. This symptom has dominated in all age group, 
in addition to more young patients. Symptoms of 
the second frequency, lump had the opposite ten-
Symptoms
Patient age-group
30-39 40-49 50-59 60-69 70-79
n % n % n % n % n %
 26 100.0 57 100.0 66 100.0 61 100.0 49 100.0
lump 24 92.3 30 52.6 38 57.6 39 63.9 29 59.2
nipple retraction - - 11 19.3 9 13.6 8 13.1 18 36.7
Pain  - - 1 1.8 2 3.0 - - -
nipple bloddy discharge - - 3 5.3 3 4.5 1 1.6 - -
localised nodularity - - 12 21.1 13 19.7 10 16.4 - -
redness and swelling 2 7.7 - - 1 1.5 3 4.9 2 4.1
Table 2.  breast cancer symptoms according to age 
Symptoms
Patient age-group
30-39 40-49 50-59 60-69 70-79
n % n % n % n % n %
 35 100.0 65 100.0 73 100.0 63 100.0 51 100.0
lump 19 54.3 15 23.1 14 19.2 10 15.9 5 9.8 P<0.01
nipple retraction  0.0 1 1.5 2 2.7 7 11.1 5 9.8
Pain 4 11.4 30 46.2 37 50.7 41 65.1 27 52.9 P<0.01
nipple bloddy 
discharge 2 5.7 5 7.7 11 15.1 3 4.8  0.0
localised 
nodularity 3 8.6 12 18.5 9 12.3 2 3.2 14 27.5
redness and 
swelling 7 20.0 2 3.1  0.0  0.0  0.0
Table 3.  benign breast symptoms according to age
Symptoms
breast changes
Malign benign total
t-test
t= P=
n Xb SD n Xb SD n Xb SD   
lump 160 55.6 13.0 63 49.1 13.4 223 53.8 13.4 3.29 P>0.01
nipple retraction 46 62.2 13.5 15 64.5 9.8 61 62.8 12.6  
Pain 3 49.7 7.5 139 58.8 11.3 142 58.6 11.3   
nipple bloody 
discharge 7 50.7 7.3 21 51.1 8.5 28 51.0 8.1  
localized 
nodularity 35 55.4 6.9 40 57.8 14.1 75 56.7 11.3  
redness and 
swelling 8 56.6 16.1 9 35.6 6.2 17 45.5 15.8 3.65 P<0.01
Table 4.  breast symptoms according to patient age – statistical parameters
SD- Standard deviation, Xb- average age, t- student t test, P- value.
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dency, decreasing according to age. The most com-
mon has been in age group 30-39, 54.3%, while in 
other age group has lower values and ranges from 
23.1%, in age 40-49 to 9.8% in age 70-79. As for 
the pain as well as lump differences according to 
age groups were significant (P <0. 01), but with 
opposite directions. Trend growth has also shown 
nipple retraction, but with lower values, from 0.0% 
in the 30-39 age group up to 11.1% of age group 
60-69. Table 4 shows breast symptoms according 
to patient age. The average age of all cases accord-
ing to symptoms was higher in cases with nipple 
retraction, 62.8 age and in the cases with pain, 58.6 
age, while cases with mastitis was younger, the av-
erage age was 45,5. Between malignant and benign 
lesions, the average age has changed significantly 
only in cases with lump and those with mastitis. 
Cases with malignant lump were older the average 
age was 55.6, to 49.1 age with benign lump. Cases 
with mastitis have significant difference according 
to age 56.6 in malign lesions to 35.6 in benign le-
sions. For other symptoms, there weren’t consider-
able changes in age. Table 5 shows that the sensi-
tivity of mammography in breast cancer detection, 
according to symptoms was variable. The higher 
sensitivity was in the nipple retraction, 89.1%, on 
average was in lump, 55,0%, while the lowest sen-
sitivity was in the cases with localized lumpiness 
or nodularity 17.1%. In the cases with rare symp-
toms like pain, nipple bloody discharge and red-
ness and swelling (mastitis), not revealed any case 
with mammography. Results of mammography 
according symptoms were statistically significant, 
that may indicate the interconnection of sensitiv-
Symptoms
Mammography detected 
lesions in breast 
yes no total
n % n % n %
Patients 135 52.1 124 47.9 259 100.0
lump 88 55.0 72 45.0 160 100.0
nipple retraction 41 89.1 5 10.9 46 100.0
Pain  0.0 3 100.0 3 100.0
nipple bloody 
discharge 0.0 7 100.0 7 100.0
localized 
nodularity 6 17.1 29 82.9 35 100.0
redness and 
swelling 0.0 8 100.0 8 100.0
Symptoms
ultrasound detected 
lesions in breast
yes no total
n % n % n %
Patients 188 72.6 71 27.4 259 100.0
lump 127 79.4 33 20.6 160 100.0
nipple retraction 37 80.4 9 19.6 46 100.0
Pain  0.0 3 100.0 3 100.0
nipple bloody 
discharge 0.0 7 100.0 7 100.0
localized 
nodularity 16 45.7 19 54.3 35 100.0
redness and 
swelling 8 100.0  0.0 8 100.0
Table 5.  Sensitivity of mammography in breast cancer diag-
nosis according to symptoms
Table 6.  Sensitivity of ultrasound in breast cancer diagnosis 
according to symptoms
Symptoms
Patient Mammography ultrasound
n n % n %
total 259 135 52.1 188 72.6
lump 160 88 55.0 127 79.4
nipple retraction 46 41 89.1 37 80.4
Pain 3  0.0  0.0
nipple bloody 
discharge 7 0.0  0.0
localised 
nodularity 35 6 17.1 16 45.7
redness and 
swelling 8  0.0 8 100.0
Symptoms
Patient Mammography ultrasound
n n % n %
total 287 212 73.9 254 88.5
lump 63 55 87.3 63 100.0
nipple retraction 15 15 100.0 15 100.0
Pain 139 117 84.2 138 99.3
nipple bloody 
discharge 21 8 38.1 12 57.1
localised 
nodularity 40 17 42.5 24 60.0
redness and 
swelling 9  0.0 2 22.2
Table 7.  comparative sensitivity of mammography and ul-
trasound in breast cancer diagnosis according to symptoms
Table 8.  Comparative specificity of mammography and ul-
trasound according to symptoms
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ity of mammography with dominant symptoms 
of patient. Table 6 shows that with ultrasound we 
obtained different results according to symptoms. 
Sensitivity was higher in cases with redness and 
swelling (mastitis carcinomatosa), 100. 0%. In 
cases with nipple retraction sensitivity was 80. 4% 
and in cases with lump was 79. 4%. The sensitiv-
ity for localized lumpiness or nodularity was 45. 
7%, while in the rare cases with nipple bloody dis-
charge and pain with ultrasound is not diagnosed. 
Table 7 shows that the comparing the sensitivity 
of mammography and ultrasound in breast can-
cer detection, according to symptoms ultrasound 
has better results in most symptoms, especially in 
redness and swelling (mastitis carcinomatosa) and 
lump, while in case with nipple retraction sensitiv-
ity was high in both methods, and the difference is 
small, in favour of mammography. In 3 cases with 
pain and 7 cases with nipple bloody discharge, 
neither method have not shown efficacy. Table 8 
shows that the specificity of mammography was 
highest in cases with nipple retraction, were diag-
nosed all the 17 cases, 100.0%. Also, specificity was 
higher on the cases with frequent symptoms, as 
lump, 87.3% and pain 84.2%. Specificity was low-
est in the nipple bloody discharge, 38.1% and local-
ized lumpiness or nodularity, 42.5%, while in cases 
with redness and swelling (mastitis) there wasn’t 
diagnosed any case. The specificity of ultrasound 
was very high in cases with lump and nipple re-
traction, 100.0% and cases with pain, 99.3%. Spec-
ificity was lowest in cases with localized lumpiness 
or nodularity, 60.0%, and nipple bloody discharge, 
57.1%, while on the weak was in the cases with 
redness ad swelling (mastitis) with only 22.2%.
Comparing the specificity of these methods 
we noted that both methods have high speci-
ficity, especially for cases with more frequent 
symptoms, but the specificity of ultrasound 
has been something higher for all symptoms. 
 
Discussion 
Breast cancer is the most common cancer as well 
as leading cause of cancer deaths in women world-
wide (21). Early detection with screening mam-
mography is the only proven way to lower mortal-
ity from breast cancer (8, 9). Signs and symptoms 
of breast cancer may include: A breast lump or 
thickening that feels different from the surround-
ing tissue, bloody discharge from the nipple, 
change in the size or shape of a breast, changes to 
the skin over the breast, such as dimpling, inverted 
nipple, peeling or flaking of the nipple skin, red-
ness or pitting of the skin over breast, like the skin 
of an orange, a lump in the underarm area. Breast 
lumps are detectable in the majority of patients 
with breast cancer (10). The incidence of this 
complaint can range from 65% to 76%, depend-
ing on the study. The typical breast cancer mass 
tends to be solitary, unilateral, solid, hard, irregu-
lar, and nontender. Breast pain is the presenting 
symptom in 5% of patients; breast enlargement, 
in 1%; skin or nipple retraction, in 5%; nipple 
discharge, in 2%; and nipple crusting or erosion, 
in 1%. Inflammatory breast cancer is particularly 
aggressive, although relatively uncommon, ac-
counting for about 5% of all breast cancers (22, 
23). More often, however, a visual examination in 
woman with a malignancy shows retraction of the 
overlying skin. This can be seen when tumours 
deep in the breast cause shortening of fibrous 
septa within the breast or when more superficial 
tumours cause direct puckering of the skin. Not 
all skin retraction necessarily results from cancer. 
Mondor disease or superficial thrombophlebi-
tis of the thoracoepigastric veins can cause skin 
retraction of the lateral aspect of the breast (24).
Visual inspection is also important in identifying 
erythema of the breast. Erythema may be second-
ary to cellulitis, recent breast irradiation, or an in-
flammatory carcinoma. Inflammatory carcinoma 
is distinguished from cellulitis by the absence of 
tenderness and fever. On breast palpation, there 
often is no definite mass, but the breast appears 
to be engorged with erythema, skin edema (peau 
d'orange), and skin ridging (25). Ultrasonography 
may be helpful in differentiating mastitis from 
inflammatory breast cancer. Spontaneous nipple 
discharge- through a mammary duct is the second 
most common sign of breast cancer. Nipple dis-
charge develops in about 3% of women with breast 
cancer but is a manifestation of benign disease in 
90% of patients. Discharge in patients older than 
50 years of age is more likely to represent cancer-
ous rather than benign conditions. Milky or pu-
rulent discharges are associated with a negligible 
chance of cancer (19). Mammography should be 
performed before any intervention. A hematoma 
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resulting from percutaneous fine-needle aspira-
tion biopsy can look similar to a small carcinoma 
(26). When such procedures have been performed 
prior to mammography, it is best to perform a 
follow-up mammogram 4 to 6 weeks later. Ultra-
sound findings can often confirm a cancer that is 
obscured mammographically by dense breast tis-
sue (3, 4, 7). Women under age 20 should not un-
dergo mammography. Ultrasound is the preferred 
diagnostic modality for young women under 30 
with a breast mass (27). If the mass is solid and 
suspicious, then mammography followed by tis-
sue diagnosis is recommended. Ultrasonography 
may be the only viable modality in pregnant and 
lactating women as it does not involve ionizing ra-
diation and also in dense breast tissue, as density 
is a limiting factor for mammography (7, 11, 13). 
Conclusions 
Our study confirmed that breast lumps are detect-
able in the majority of patients with breast cancer 
and constitute the most common sign on history 
and physical examination. The most frequent symp-
toms in patient with benign lesions were pain or 
localized discomfort. Sensitivity of mammography 
is diminished when the breast tissue is dense. The 
diagnostic accuracy for carcinomas of the breast 
and for benign lesions according to symptoms 
was higher for ultrasound than for mammography. 
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